Literature DB >> 33424480

Role of Rehabilitation in Promoting Engagement in Daily Life in Multiple Sclerosis: Facing the Challenges of the 21st Century.

Niels Peeters, Inger Grethe Løyning, Sofie Ferdinand, Daphne Kos.   

Abstract

The purpose of this narrative review is to define the theoretical constructs of engagement, participation, and balance. The implementation of these constructs in multiple sclerosis (MS) rehabilitation are described because MS symptoms such as fatigue and cognitive decline may affect engagement in daily life. The constructs of engagement and participation can be considered to be different when they are studied. The constructs related to balance are of interest when targeting engagement. Multidisciplinary rehabilitation programs may have beneficial effects in optimizing engagement. Therefore, the measurement of these constructs is primordial because they give us a deeper understanding of the meaning of activity performance that reflects engagement in daily life. Future research may focus on describing engagement in both men and women at all stages of MS and may explore variables that influence engagement in daily life to integrate engagement optimization in MS rehabilitation. Engagement may have beneficial effects as part of multidisciplinary rehabilitation in MS.
© 2020 Consortium of Multiple Sclerosis Centers.

Entities:  

Keywords:  Activities of daily living (ADLs); Balance; Engagement; Multiple sclerosis (MS); Participation; Rehabilitation

Year:  2020        PMID: 33424480      PMCID: PMC7780697          DOI: 10.7224/1537-2073.2019-094

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  22 in total

Review 1.  Untangling occupation and activity.

Authors:  D Pierce
Journal:  Am J Occup Ther       Date:  2001 Mar-Apr

2.  Life balance and perceived stress: predictors and demographic profile.

Authors:  Kathleen Matuska; Julie Bass; John S Schmitt
Journal:  OTJR (Thorofare N J)       Date:  2013

3.  Activity limitations and participation restrictions in people with multiple sclerosis: a detailed 10-year perspective.

Authors:  David Conradsson; Charlotte Ytterberg; Catharina Engelkes; Sverker Johansson; Kristina Gottberg
Journal:  Disabil Rehabil       Date:  2019-06-13       Impact factor: 3.033

4.  Participation as an Outcome in Multiple Sclerosis Falls-Prevention Research: Consensus Recommendation from the International MS Falls Prevention Research Network.

Authors:  Marcia Finlayson; Elizabeth Peterson; Patricia N Matsuda
Journal:  Int J MS Care       Date:  2014

Review 5.  Rehabilitation in Multiple Sclerosis: A Systematic Review of Systematic Reviews.

Authors:  Fary Khan; Bhasker Amatya
Journal:  Arch Phys Med Rehabil       Date:  2016-05-20       Impact factor: 3.966

6.  Correlates of participation in meaningful activities among people with multiple sclerosis.

Authors:  Matthew A Plow; Marcia Finlayson; Douglas Gunzler; Allen W Heinemann
Journal:  J Rehabil Med       Date:  2015-06       Impact factor: 2.912

7.  Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews.

Authors:  Bhasker Amatya; Fary Khan; Mary Galea
Journal:  Cochrane Database Syst Rev       Date:  2019-01-14

Review 8.  Occupational Therapy in Fatigue Management in Multiple Sclerosis: An Umbrella Review.

Authors:  Angela Salomè; Tullia Sasso D'Elia; Giorgia Franchini; Valter Santilli; Teresa Paolucci
Journal:  Mult Scler Int       Date:  2019-03-21

9.  A cognitive occupation-based programme for people with multiple sclerosis: A new occupational therapy cognitive rehabilitation intervention.

Authors:  Sinéad M Hynes; Susan Forwell
Journal:  Hong Kong J Occup Ther       Date:  2019-05-08       Impact factor: 0.917

Review 10.  A systematic review of the effectiveness of self-management interventions in people with multiple sclerosis at improving depression, anxiety and quality of life.

Authors:  Tara Kidd; Nicola Carey; Freda Mold; Sue Westwood; Maria Miklaucich; Emmanouela Konstantara; Annette Sterr; Debbie Cooke
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.